Broadened T-cell repertoire diversity in ivIg-treated SLE patients is also related to the individual status of regulatory T-cells

Journal of Clinical Immunology

Volumn 33, Issue 2, 2013, Pages 349-360

  Costa, Nuno ^a   Pires, Ana E ^b,m,n   Gabriel, Ana M ^a   Goulart, Luiz F ^a   Pereira, Clara ^c   Leal, Bárbara ^c   Queiros, Ana C ^b   Chaara, Wahiba ^d,e,f   Moraes Fontes, Maria F ^a,h   Vasconcelos, Carlos ^g   Ferreira, Carlos ^h   Martins, Jorge ⁱ   Bastos, Marina ^j   Santos, Maria J ^k   Pereira, Maria A ^a,l   Martins, Berta ^c   Lima, Margarida ^g   João, Cristina ^b   Six, Adrien ^d,e   Demengeot, Jocelyne ^a   Fesel, Constantin ^a   more..

^a INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

^d SORBONNE UNIVERSITÉ   (France)

^e CNRS   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^h HOSPITAL DE SANTA MARIA   (Portugal)

ⁱ Estrada dos Marmeleiros Monte   (Portugal)

^j Hospital Sao Teotonio   (Portugal)

^k HOSPITAL GARCIA DE ORTA   (Portugal)

^l HOSPITAL DE FARO   (Portugal)

^m INSTITUTO NACIONAL DE INVESTIGAÇÃO AGRÁRIA E VETERINÁRIA   (Portugal)

ⁿ UNIVERSITY OF LISBON   (Portugal)

more..

Author keywords

Autoimmunity; CD25; Intravenous IgG; Regulatory T cells; Systemic lupus erythematosus; TCR spectratypes

Indexed keywords

CD4 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTOMETRY; DRUG INFUSION; DRUG RESPONSE; FEMALE; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN FAMILY; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

EID: 84879881255     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9816-7     Document Type: Article

References (58)

1. Arnson Y, Shoenfeld Y, Amital H. Intravenous immunoglobulin therapy for autoimmune diseases. Autoimmunity. 2009;42(6):553-60.
2. Levy Y, Sherer Y, Ahmed A, Langevitz P, George J, Fabbrizzi F, et al. A study of 20 SLE patients with intravenous immunoglobulin - clinical and serologic response. Lupus. 1999;8(9):705-12.
3. Zandman-Goddard G, Blank M, Shoenfeld Y. Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside. Lupus. 2009;18(10):884-8.
4. Nimmerjahn F, Ravetch JV. Antibody-mediated modulation of immune responses. Immunol Rev. 2010;236:265-75.
5. Smith KGC, Clatworthy MR. Fc gamma RIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol. 2010;10(5):328-43.
6. Joao C, Ogle BM, Gay-Rabinstein C, Platt JL, Cascalho M. B Cell-dependent TCR diversification. J Immunol. 2004;172 (8):4709-16.
7. Joao C, Ogle BM, Geyer S. Immunoglobulin promotes the diversity and the function of T cells. Eur J Immunol. 2006;36(7):1718-28.
8. Pires AE, Afonso AF, Queiros A, Cabral MS, Porrata L, Markovic SN, et al. Treatment With Polyclonal Immunoglobulin During Tcell Reconstitution Promotes Naive T-cell Proliferation. J Immunother. 2010;33(6):618-25.
9. Kessel A, Ammuri H, Peri R, Pavlotzky ER, Blank M, Shoenfeld Y, et al. Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function. J Immunol. 2007;179:5571-5.
10. De Groot AS, Moise L, McMurry JA, Wambre E, Van Overtvelt L, Moingeon P, et al. Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". Blood. 2008;112(8):3303-11.
11. Ephrem A, Chamat S, Miquel C, Fisson S, Mouthon L, Caligiuri G, et al. Expansion of CD4(+)CD25(+) regulatory Tcells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis. Blood. 2008;111(2):715-22.
12. Maddur MS, Othy S, Hegde P, Vani J, Lacroix-Desmazes S, Bayry J, et al. Immunomodulation by Intravenous Immunoglobulin: Role of Regulatory T Cells. J Clin Immunol. 2010;30:S4-8.
13. Olivito B, Taddio A, Simonini G, Massai C, Ciullini S, Gambineri E, et al. Defective FOXP3 expression in patients with acute Kawasaki disease and restoration by intravenous immunoglobulin therapy. Clin Exp Rheumatol. 2010;28(1 Suppl 57):93-7.
14. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3(+) regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490-500.
15. Scheinecker C, Bonelli M, Smolen JS. Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells. J Autoimmun. 2010;35(3):269-75.
16. Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4(+)CD25 (high) T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol. 2007;178(4):2579-88.
17. Bonelli M, Savitskaya A, Steiner CW, Rath E, Smolen JS, Scheinecker C. Phenotypic and Functional Analysis of CD4(+)CD25(-)Foxp3(+) T Cells in Patients with Systemic Lupus Erythematosus. J Immunol. 2009;182(3):1689-95.
18. Horwitz DA. Identity of mysterious CD4(+)CD25(-)Foxp3(+) cells in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(1):201.
19. Zheng L, Sharma R, Kung JT, Deshmukh US, Jarjour WN, Fu SM, et al. Pervasive and stochastic changes in the TCR repertoire of regulatory T-cell-deficient mice. Int Immunol. 2008;20(4):517-23.
20. Zennaro D, Scala E, Pomponi D, Caprini E, Arcelli D, Gambineri E, et al. Proteomics plus genomics approaches in primary immunodeficiency: the case of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Clin Exp Immunol. 2012;167(1):120-8.
21. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta-chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA. 1993;90(9):4319-23.
22. Fitzgerald JE, Ricalton NS, Meyer AC, West SG, Kaplan H, Behrendt C, et al. Analysis of clonal CD8(+) T-cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol. 1995;154(7):3538-47.
23. Gulwani-Akolkar B, Akolkar PN, Minassian A, Pergolizzi R, McKinley M, Mullin G, et al. Selective expansion of specific T cell receptors in the inflamed colon of Crohn's disease. J Clin Invest. 1996;98(6):1344-54.
24. Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA. 1998;95(24):14447- 52.
25. Matsumoto Y, Yoon WK, Jee Y, Fujihara K, Misu T, Sato S, et al. Complementarity-determining region 3 spectratyping analysis of the TCR repertoire in multiple sclerosis. J Immunol. 2003;170 (9):4846-53.
26. Diluvio L, Vollmer S, Besgen P, Ellwart JW, Chimenti S, Prinz JC. Identical TCR beta-chain rearrangements in streptococcal angina and skin lesions of patients with psoriasis vulgaris. J Immunol. 2006;176(11):7104-11.
27. Matsumoto Y, Matsuo H, Sakuma H, Park IK, Tsukada Y, Kohyama K, et al. CDR3 spectratyping analysis of the TCR repertoire in myasthenia gravis. J Immunol. 2006;176(8):5100-7.
28. Olive C, Gatenby PA, Serjeantson SW. Restricted junctional diversity of T-cell receptor delta-gene rearrangements expressed in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol. 1994;97(3):430-8.
29. Holbrook MR, Tighe PJ, Powell RJ. Restrictions of T cell receptor beta chain repertoire in the peripheral blood of patients with systemic lupus erythematosus. Ann Rheum Dis. 1996;55(9):627-31.
30. Kolowos W, Herrmann M, Ponner BB, Voll R, Kern P, Frank C, et al. Detection of restricted junctional diversity of peripheral T cells in SLE patients by spectratyping. Lupus. 1997;6(9):701-7.
31. Fraser PA, Lu LY, DeCeulaer K, Schur PH, Fici D, Awdeh Z, et al. CD4 TCRBV CDR3 analysis in prevalent SLE cases from two ethnic groups. Lupus. 1999;8(4):311-9.
32. Kato T, Kurokawa M, Sasakawa H, Masuko-Hongo K, Matsui T, Sekine T, et al. Analysis of accumulated T cell clonotypes in patients with systemic lupus erythematosus. Arthritis Rheum. 2000;43(12):2712-21.
33. Massengill SF, Goodenow MM, Sleasman JW. SLE nephritis is associated with an oligoclonal expansion of intrarenal T cells. Am J Kidney Dis. 1998;31(3):418-26.
34. Collette A, Six A. ISEApeaks: an Excel platform for Gene Scan and Immunoscope data retrieval, management and analysis. Bioinformatics. 2002;18(2):329-30.
35. Collette A, Cazenave PA, Pied S, Six A. New methods and software tools for high throughput CDR3 spectratyping. Application to T lymphocyte repertoire modifications during experimental malaria. J Immunol Meth. 2003;278(1-2):105-16.
36. Gorochov G, Neumann AU, Kereveur A, Parizot C, Li TS, Katlama C, et al. Perturbation of CD4(+) and CD8(+) T-cell repertoires during progression to AIDS and regulation of the CD4(+) repertoire during antiviral therapy. Nat Med. 1998;4(2):215-21.
37. Han M, Harrison L, Kehn P, Stevenson K, Currier J, Robinson MA. Invariant or highly conserved TCR alpha are expressed on double-negative (CD3(+)CD4(-)CD8(-)) and CD8(+) T cells. J Immunol. 1999;163(1):301-11.
38. Rosner B. A Generalization of the Paired t-Test. Appl Statist. 1982;31(1):9-13.
39. Press W. Numerical Recipes in C. Cambridge: Cambridge University Press; 1994.
40. R development Core Team (2012) R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing
41. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, et al. Functional Delineation and Differentiation Dynamics of Human CD4(+) T Cells Expressing the FoxP3 Transcription Factor. Immunity. 2009;30(6):899-911.
42. Lawson TM, Man S, Williams S, Boon ACM, Zambon M, Borysiewicz LK. Influenza A antigen exposure selects dominant V(beta)17(+) TCR in human CD8(+) cytotoxic T cell responses. Int Immunol. 2001;13(11):1373-81.
43. Turner SJ, Doherty PC, McCluskey J, Rossjohn J. Structural determinants of T-cell receptor bias in immunity. Nat Rev Immunol. 2006;6(12):883-94.
44. Gras S, Kjer-Nielsen L, Burrows SR, McCluskey J, Rossjohn J. T-cell receptor bias and immunity. Curr Opin Immunol. 2008;20(1):119-25.
45. Miles JJ, Thammanichanond D, Moneer S, Nivarthi UK, Kjer-Nielsen L, Tracy SL, et al. Antigen-Driven Patterns of TCR Bias Are Shared across Diverse Outcomes of Human Hepatitis C Virus Infection. J Immunol. 2011;186(2):901-12.
46. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, Chapuis B, et al. Recovery of immune reactivity after T-celldepleted bone marrow transplantation depends on thymic activity. Blood. 2000;96(6):2299-303.
47. Hirokawa M, Matsutani T, Horiuchi T, Kawabata Y, Kitabayashi A, Yoshioka T, et al. Extensive clonal expansion of T lymphocytes causes contracted diversity of complementarity-determining region 3 and skewed T cell receptor repertoires after allogeneic hematopoietic cell transplantation. Bone Marrow Transplan. 2001;27(6):607-14.
48. Talvensarri K, Clave E, Douay C, Rabian C, Garderet L, Busson M, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood. 2002;99 (4):1458-64.
49. Kou ZC, Puhr JS, Wu SS, Goodenow MM, Sleasman JW. Combination Antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children. J Infect Dis. 2003;187(3):385-97.
50. Ria F, Penitente R, De Santis M, Nicolo C, Di Sante G, Orsini M, et al. Collagen-specific T-cell repertoire in blood and synovial fluid varies with disease activity in early rheumatoid arthritis. Arthritis Res Ther. 2008;10(6):R135.
51. Jacobi AM, Diamond B. Balancing diversity and tolerance: lessons from patients with systemic lupus erythematosus. J Exp Med. 2005;202(3):341-4.
52. Crispin JC, Martinez A, Alcocer-Varela J. Quantification of regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun. 2003;21(3):273-6.
53. Liu MF, Wang CR, Fung LL, Wu CR. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol. 2004;59:198-202.
54. Miyara M, Amoura Z, Parizot C, Badoual C, Dorgham K, Trad S, et al. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J Immunol. 2005;175(12):8392-400.
55. Lee JH, Wang LC, Lin YT, Yang YH, Lin DT, Chiang BL. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology. 2006;117:280-6.
56. Joao C. Immunoglobulin is a highly diverse self-molecule that improves cellular diversity and function during immune reconstitution. Med Hypotheses. 2007;68(1):158-61.
57. Pacholczyk R, Kern J. The T-cell receptor repertoire of regulatory T cells. Immunology. 2008;125(4):450-8.
58. Aubin E, Lemieux R, Bazin R. Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation. Blood. 2010;115(9):1727-34.